Gene therapy may successfully treat chronic painJanuary 22nd, 2008 - 12:53 pm ICT by admin
Washington, Jan 22 (ANI): Chronic pain can be successfully treated with a novel targeted gene therapy, according to researchers in the Department of Medicine and Department of Neurosciences at Mount Sinai School of Medicine.
The rat-model based study, led by Dr. Andreas Beutler, MD, Assistant Professor of Medicine/ Hematology And Medical Oncology at Mount Sinai School of Medicine, suggests that gene therapy for pain might in the future become a treatment alternative for patients with severe chronic pain.
In the study, the researchers developed a gene therapy technique that simulates the pain-killing effect of opiate drugs.
Chronic pain patients often do not experience satisfactory pain relief from available treatments due to poor efficacy or intolerable side effects like extreme sleepiness, mental clouding, and hallucinations, said Beutler.
Researchers designed a viral vector to carry the prepro-b-endorphin gene into primary sensory neurons in order to activate opiate receptors selectively, in the rat model.
The agents were delivered directly into the spinal fluid of rats via a lumbar puncture, or spinal tap with only one injection.
Results showed that the rats remained symptom-free for an extended period of time.
Our research found that treating chronic pain with Adeno-Associated Virus vector-based gene therapy allows for pain relief for more than three months after a single injection, targeting selectively the pain gate. The technique worked successfully with opioid- and non-opioid therapeutic genes, said Beutler.
Targeted gene therapy will likely avoid the unwanted side effects associated with opioid painkillers such as morphine. Based on our findings, this targeted gene therapy via lumbar puncture appears to be a promising candidate for bench-to-bedside research that might ultimately be tested in patients with intractable chronic pain, e.g., to help patients suffering from severe pain due to advanced cancer, said Beutler.
Th e study Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain has been published in the Proceedings of the National Academy of Sciences (PNAS). (ANI)
- Mood, anxiety disorders patients likely to abuse painkillers - Dec 14, 2011
- Breakthrough to help block morphine addiction - Aug 16, 2012
- Chilli compound shows pain relief promise - Dec 22, 2010
- Novel gene therapy for cancer pain proves successful in small trial - Apr 12, 2011
- Single shot of morphine has long lasting effects on testosterone levels - Nov 04, 2010
- New finding to make morphine a safer, more effective drug - Mar 25, 2011
- Risk factors for painkiller addiction identified - Aug 29, 2010
- Spinal manipulation may ease chronic lower back pain: Study - Feb 16, 2011
- Test to detect Alzheimer's at its earliest stage 'seems possible' - Dec 22, 2010
- Prescriptions for painkillers stepping stone for drug addiction - Aug 21, 2010
- Opioids now most prescribed class of medications in US - Apr 06, 2011
- Genetic study sheds light on chronic pain - May 07, 2010
- Common pain relief drugs promote cancer growth - Nov 19, 2009
- Botox 'can alleviate severe spinal headaches' - Apr 15, 2011
- Nerve cell memory holds key erasing pain - Feb 14, 2012
Tags: bench to bedside, beutler, chronic pain patients, gene therapy technique, lumbar puncture, medical oncology, mount sinai school, mount sinai school of medicine, opiate drugs, opiate receptors, poor efficacy, promising candidate, rat model, school of medicine, sensory neurons, spinal tap, therapeutic genes, unwanted side effects, viral vector, virus vector